Management of patients with sickle cell disease
- PMID: 25562274
- PMCID: PMC4896487
- DOI: 10.1001/jama.2014.15898
Management of patients with sickle cell disease
Comment in
-
Management of patients with sickle cell disease--reply.JAMA. 2015 Jan 6;313(1):91-2. doi: 10.1001/jama.2014.15909. JAMA. 2015. PMID: 25562275 No abstract available.
Comment on
-
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.JAMA. 2014 Sep 10;312(10):1033-48. doi: 10.1001/jama.2014.10517. JAMA. 2014. PMID: 25203083 Review.
References
-
- Klings ES, Machado RF, Barst RJ, et al. American Thoracic Society Ad Hoc Committee on Pulmonary Hypertension of Sickle Cell Disease. An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. Am J Respir Crit Care Med. 2014;189(6):727–740. - PMC - PubMed
-
- Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA. 2014;312(10):1033–1048. - PubMed
-
- Hoeper MM, Bogaard HJ, Condliffe R, et al. Definitions and diagnosis of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 (suppl)):D42–D50. - PubMed
-
- Klings ES, Anton Bland D, Rosenman D, et al. Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression. Am J Hematol. 2008;83(7):547–553. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
